Costa, L. J., Maddocks, K., Epperla, N., Reddy, N. M., Karmali, R., Umyarova, E., Bachanova, V., Costa, C., Glenn, M. J., Chavez, J. C., Calzada, O., Lansigan, F., Nasheed, H., Barta, S. K., Zhou, Z., Jaglal, M., Chhabra, S., Hernandez‐Ilizaliturri, F., Xavier, A. C., Mehta, A., Peker, D., Forero‐Torres, A., Al‐Mansour, Z., Evens, A. M., Cohen, J. B., Flowers, C. R., Fenske, T. S., & Hamadani, M. (n.d.). diffuse large B‐cell lymphoma with primary treatment failure: Ultra‐high risk features and benchmarking for experimental therapies. American journal of hematology, 92(2), 161–170. http://access.bl.uk/ark:/81055/vdc_100040554778.0x000032